Back to mobile site

Jefferies Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

March 10, 2026 12:01 PM EDT Send to a Friend
Jefferies analyst Cui Cui reiterated a Buy rating and $69.00 price target on Legend Biotech Corp. (NASDAQ: LEGN)The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login